stockrowGenmab A/S Sponsored ADR
GMAB Healthcare Biotechnology
Genmab A/S Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, up 19.2% from fiscal 2024.
- Revenue
- +24.9%
- EPS
- −9.26%
- Free cash flow
- −7.69%
Quarter to June 2026, against a year earlier
Follow GMAB
Alert me
Genmab A/S Sponsored ADR (GMAB) Operating margin
Genmab A/S Sponsored ADR's operating margin over the twelve months to 30 June 2026 was 26.0%, down 2.7 percentage points from fiscal 2025 (28.6%). Over the past ten years it has ranged from 28.6% (fiscal 2025) to 116.0% (fiscal 2016) — the current reading is the lowest in ten years. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 28.6% | (2.51) |
| FY2024 | 31.1% | (1.16) |
| FY2023 | 32.3% | (11.26) |
| FY2022 | 43.6% | 7.98 |
| FY2021 | 35.6% | (26.86) |
| FY2020 | 62.4% | 13.28 |
| FY2019 | 49.2% | 3.53 |
| FY2018 | 45.6% | (69.89) |
| FY2017 | 115.5% | (0.45) |
| FY2016 | 116.0% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 32.5% | 12.38 |
| Mar 2026 | 20.1% | 14.61 |
| Dec 2025 | 5.48% | (39.43) |
| Sep 2025 | 44.9% | 5.99 |
| 27 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| RPRX Royalty Pharma PLC compare | 57.1% |
| GMAB Genmab A/S Sponsored ADR | 26.0% |
| ALNY Alnylam Pharmaceuticals, Inc. compare | 19.5% |
| ONC BeOne Medicines Ltd. - Sponsored ADR compare | 17.8% |
| INCY Incyte Corporation compare | 10.4% |
| INSM Insmed, Inc. compare | −37.1% |
| BNTX BioNTech SE Sponsored ADR compare | −79.0% |
| RVMD Revolution Medicines, Inc. compare | −805.8% |
| ROIV Roivant Sciences Ltd. compare | −7,914.8% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on GMAB
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement